SUMMER TRAINING REPORT ON

“EMPLOYEE SATISFACTION AT LARK LABORATORIES

INDIA”

SUBMITTED IN THE PARTIAL FULFILLMENT OF THE REQUIREMENT FOR

THE AWARD OF THE DEGREE OF BACHELOR OF BUSINESS ADMINISTRATION
SUBMITTED TO:
Mrs.pooja dabas Nikita takiar
Assistant Professor Roll Number: 06021201715
Department of Business Administraion BBA (GENERAL) 5th Semester 2ndShift

Maharaja Surajmal
Institute
An ISO-9001:2000 Certified Institute

Recognized by UGC u/s 2(f)

(Affiliated to Guru Gobind Singh Indraprastha University)

C-4, Janakpuri, New Delhi-110058

1
 CERTIFICATE OF
ACKNOWLEDGEMENT

I take this opportunity to express my sincere gratitude to all concerned with the successful
completion of project. I would like to thank Mrs. Pooja dabbas who helped me with my queries,
which helped me in the completion of the project.

I would also like to thank all those respondents who were patient enough in giving answer to the
questionnaire.

They have provided me with the valuable guidance, sustained efforts and friendly approach. It is
worthless, if I don’t pay my gratitude to all faculty members for their positive co-operation to
complete my project in a significant manner.

Nikita Takiar

BBA (GENERAL) 5rd SEMESTER 2nd Shift

Roll Number: 06021201715

2
 TABLE OF CONTENTS

S.No. CONTENTS PAGE NO.

Chapter 1 Introduction 6

1.1 Objectives of the Study 8

1.2 Research Methodology 8

1.3 Limitations of the Study 8-9

Chapter 2 Company profile 10

2.1 History 11-12

2.2 Product Development 13-24

2.3 Products comparison 25-28

Chapter 3 Review of literature 29-31

Chapter 4 Data analysis and interpretation 32-51

Chapter 5 Conclusion and Recommendation 52-53

5.1 Questionnaire 54-56

5.2 Bibliography 57

3
 CHAPTER 1
INTRODUCTION

4
 Introduction

WHO WE ARE

We represent a relationship… of trust and reliability in the field of pharmaceutical formulations

manufacturing for over35 years with in-house R&D facilities. Lark Laboratories (India)
Limited established in year 1979, is one of India’s fastest growing and reputed pharmaceutical
manufacturing company and is committed to provide the better health for healthy life at an most
affordable price across the globe through qualitative products. By combining Strategic Research and
Expertise in pharmaceutical manufacturing, industry knowledge Lark laboratories (India) Limited is
transforming itself into a prestigious and reputed pharmaceutical formulations manufacturing company
based at India. A State of Art manufacturing unit with facilities for OSD, Liquids and Topical was set up
in year 2002 with a separate dedicated R&D Facilities based at Bhiwadi Rajasthan just 85kms away from
the capital city of New Delhi adhering to the guidelines as stipulated by WHO GMP standards accredited
by WHO-GMP and ISO – 9001:2008.
Further the manufacturing facilities are accredited by PPB-Malawi, FBD-Ghana, MOH-Tajikistan,
MOH-DR Congo, MOH-Ivory Coast, MCAZ-Zimbabwe, NAFDAC-Nigeria and MOH-NEPAL. The
factory is scheduled for inspection from PPB-Kenya, TFDA-Tanzania, MOH-Sudan and FDA-
Philippines soon
Lark Laboratories (India) Limited has a robust product portfolio spread over major product segments
encompassing Anti-Biotic, Gynecological , Gastroenterological, Anti-Allergic, Anti-Fungal, , Pediatrics,
Orthopedics, Cardiovascular, Anti-Diabetic, , Anti-Retroviral, Anti-Psychotics, Topical
Preparations. Lark Laboratories (India) Limited is having a strong presence across 20 states of India for
its Ethical products and is growing at a brisk rate. Apart from Ethical business Lark caters to prestigious
government institutions like ESIC, DGFMS, CGHS and other state governments. Apart from domestic
arena Lark has already achieved the distinction of having a global presence in over 35 countries across
the globe catering to CIS, S.E. Asia, Africa, LAC, M.E etc. Lark is moving ahead with an aim to have
prestigious PIC/S certification along with EU-GMP Certifications in years to come and slowly
moving in the same direction.

Lark Laboratories (India) limited is having a MISSION to:

 Reach out the Masses
 Make World a Better and Healthy place to Live
 Ensure Right to proper Health Care for Every Living Being
 Providing affordable medicines of highest quality


5
Lark Laboratories (I) limited is having a VISSION to:
 Soar Heights beyond Expectations
 Obtain a self regulated zero defect system in working

AT LARK WE BELIEVE
MAKING MONEY IS AN ART,
WORKING FOR IT IS AN ART,
BUT MAKING HEALTHY LONG LASTING BUSINESS IS
“BEST ART OF ALL”
LEADERSHIP : THE COURAGE TO SHAPE A BETTER FUTURE
COLLABORATION : LEVERAGE COLLECTIVE GENIUS
INTEGRITY : BE REAL

OBJECTIVES OF THE STUDY:

Although there were many underlying goals, here are the Main Objectives of my Summer
Training Report :

• To study the working of firms in the pharmaceutical industry

• To understand the working of the HR department of Lark Laboratories India Ltd.
• Work and gain knowledge of real business environment and experience corporate culture.

• To understand the employee satisfaction level at Lark Lab with respect to various aspects.
• To suggest measures to the company for improving their Human Resource.
• To make sure that suggested measures help improve employee satisfaction at the firm.

6
RESEARCH METHODOLGY:

Starting a research project needs a basic preparation regarding the issues related to the topic
selected. For this one needs to do some deskwork. Deskwork includes:

1. Determining the basic objectives of the study undertaken.

2. Collection of secondary data related to the topic from Internet, magazines & newspapers.

3. Study the pharmaceutical company.

4. Analyze the objective on the basis of information collected by secondary data.

All the above activities at the initial stage of the project must be completed & then the main
part follows.

LIMITATIONS OF THE STUDY:

Although I tried to conduct this research with full authenticity and accuracy, some
limitations to the method of primary data collection via questionnaire exist. The
ones faced by me are :

 Opinions of the employees were collected and certain factors external to the firm
could have been ignored.
 Time period was limited and short to understand the company profile in depth.
 There was a lack of interest shown by the respondents which resulted in
incomplete responses.

 The conclusion arrived at, are based on a very less experience of researcher in this
field and could have been affected by bias.

 Employees may not have been entirely honest due to hesitation of management’s
reaction or judgement from researcher. This makes the data sort of inaccurate and
unreliable.

7
 Respondents could have had trouble in understanding of questions even though I
tried to keep the questions in simple language and direct.

8
 CHAPTER 2
COMPANY PROFILE

9
2.1 HISTORY OF LARK LABORATORY:

Lark Laboratories (india) Ltd is a Public incorporated on 11 April 1979. It is classified as Non-govt
company and is registered at Registrar of Companies, Delhi. Its authorized share capital is Rs.
50,000,000 and its paid up capital is Rs. 42,568,600. It is inolved in Manufacture of other chemical
products

Lark Laboratories (india) Ltd's Annual General Meeting (AGM) was last held on 23 September 2017
and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31
March 2017.

Directors of Lark Laboratories (india) Ltd are Aprajita Takiar, Badri Bishal Tikmani, Vijay Kumar
Gupta, Kantilal Vajeraj Jain, Raj Monga, Kamal Prabha Anand, Vijay Uppal, Virender Uppal, .

Lark Laboratories (india) Ltd's Corporate Identification Number is (CIN) U24230DL1979PLC009548

and its registration number is 9548.Its Email address is kck_112000@yahoo.co.in and its registered
address is A-105/2 OKHLA INDUSTRIAL AREAPHASE II NEW DELHI DL 110020 IN , - , .

10
Current status of Lark Laboratories (india) Ltd is - Active.

Company Details

CIN U24230DL1979PLC009548

Company Name LARK LABORATORIES (INDIA)

LTD

Company Status Active

RoC RoC-Delhi

Registration 9548
Number

Company Company limited by Shares

Category

Company Sub Non-govt company

Category

Class of Public
Company

Date of 11 April 1979

Incorporation

Age of Company 39 years, 8 month, 15 days

Activity Manufacture of other chemical

products

11
 Product features and specification


TRADE NAME COMPOSITION

Each vaginal tablet contains

INFA VT tablets Tinidazole 500mg

Clotrimazole 200mg

Lactic acid bacillus 150 million spores

Each 1 gm contains

INFA VT OINTMENT Tinidazole 5%

Clotrimazole 2%

Each ml contains

KLEAN V LACTIC ACID

ALOE VERA

MILK PROTEIN

Each tablel contains

SPASMOLAR Dicyclomine Hcl 10mg

Clidinium Bromide 2.5mg

Paracetamol 325mg

Activated Dimethicone 25mg

COL 3 Each 1 gm sachet contains

Cholecalciferol 60000 I.U

Each 5 ml contains

BOWLEASE Lactulose 3.325g

PEDIATRICS

BOULAR Each 765mg contains

12
 Saccharomyces boulardii 282.5mg

Each 5ml contains

CLAVIMOX PLUS Amoxycillin 200mg

Clavulanic acid 28.5mg

COL 3 DROP Each ml contains

Cholecalciferol 800 I.U

Each 1 gm contains

RASHNIL Zasad 15%

Aloe vera 10%

Neem extract 1.50%

Coconut oil 2%

Each 5 ml contains

LIVOGARD FORTE L – Ornithine L- Aspartate 150mg

Zinc 2.5mg

Selenium 100mcg

Niacinamide 45mg

Vitamin B6 1.5mcg

Vitamin B12 5mcg

Each ml contains

PIPLAR D Dyclomine 10mg

Simethicone 40mg

Each 5ml contains

DOLAR Dextromethorphan 7.5mg

Phenylephrine 5mg

Bromhexine 4mg

CIPROLAR Ciprofloxacin 250mg

PHYSICIAN / GENERAL PRACTIONER

Each 5 ml contains

13
LIVOGARD PLUS Silymarin 40mg

L- Ornithine – L Aspartate 150mg

Zinc 2.5mg

Selenium 100mcg

Vitamin B6 1.5mg

Vitamin B12 5mcg

Niacinamide 45mg

Each tablet contains

PANDOM Pantoprazole 40mg

Domperidone 10mg

Each 5 ml contains

RICHZYME Pepsin 10mg

Fungal diastase 50mg

Each tablet contains

CLAVIMOX Amoxycillin 500mg

Clavulanic acid 125mg

Each tablet contains

P- MOX D Amoxycillin 250mg

Dicloxacillin 250mg

Each tablet contains

LARMYCETIN Chloramphenicol 250mg/500mg

Each 5 ml contains

Ambroxol 15mg

DOLAR BM Guaiphenesin 50mg

Terbutaline 1.25mg

Menthol 2.5mg

Each tablet contains

Chlorpheniramine 4mg

14
CONTROL Phenylephrine 10mg

Paracetamol 325mg

Caffeine 20mg

Each tablet contains

AZOFEN- T Ketotifen fumerate 1mg

Theophylline 200mg

Each tablet contains

LARGYL N Norfloxacin 200mg

Metronidazole 200mg

Each tablet contains

FLOX Norfloxacin 400mg

Each tablet contains

KINASE N Serratiopeptidase 10mg

Nimesulide 100mg

Each tablet contains

SYMOLAR FORTE Trypsin

Chymotrypsin

Each tablet contains

QUEENOLAR QUININE SULPHATE 150MG/300MG

Each tablet contains

LARQUIN Chloroquin phosphate 250/500mg

Each 5 ml contains

Sulphadoxine 250mg

Pyrimethamine 12.5mg

Each tablet contains

LARFAN Artemether 20 mg

Lumefantrine 480mg

Each tablet contains

15
LARGYL O Ofloxacin 200mg

Ornidazole 500mg

Each gm contains

Ciprofloxacin 0.50%

CIPROLAR FC Fluocinolone 0.03%

Clotrimazole 1.00%

Each tablet contains

BETALAR S Betamethasone sodium phosphate 0.5mg

Each ml contains

BETALAR DROP Betamethasone sodium phosphate 0.5mg

Each tablet contains

LARKIN Paracetamol 500mg

Each tablet contains

FAZIM 100 Clofazamine 50/100 mg

ORTHOPEDICS

Each tablet contains

DICA Diacerin 50mg

Aceclofenac 100mg

Each tablet contains

SAP Serratiopeptidase 15mg

Aceclofenac 100mg

Paracetamol 325mg

ENT

Each tablet contains

Montelukast 10 mg

MONTELAR levocetrizine 5mg

Each 5 ml contains

16
 Montelukast 4mg

Levocetrizine 2.5mg

Each tablet contains

levocetrizine 2.5mg

LEVLAR Phenylephrine 5mg

Ambroxol 60mg

Paracetamol 325mg

Each 5 ml contains

LEVLAR SUSP levocetrizine 2.5mg

Ambroxol 15mg

GASTRO

Each tablet contains

LIVOGARD L- Ornithine – L Aspartate 150mg

Pancreatin 100mg

LIVOGARD INF. L- Ornithine – L Aspartate 5gm

17
CHAPTER:3 REVIEW OF
LITERATURE

18
 The pharmaceutical industry discovers, develops, produces, and
markets drugs or pharmaceutical drugs for use as medications to be administered
(or self-administered) to patients to cure them, vaccinate them, or alleviate
a symptom. Pharmaceutical companies may deal in generic or brand medications
and medical devices. They are subject to a variety of laws and regulations that
govern the patenting, testing, safety, efficacy and marketing of drugs.

The modern pharmaceutical industry traces its roots to two sources. The first of these
were local apothecaries that expanded from their traditional role distributing botanical
drugs such as morphine and quinine to wholesale manufacture in the mid 1800s.
Rational drug discoveryfrom plants started particularly with the isolation of morphine,
analgesic and sleep-inducing agent from opium, by the German apothecary assistant
Friedrich Sertürner who named the compound after the Greek god of
dreams, Morpheus.[3] By the late 1880s, German dye manufacturers had perfected the
purification of individual organic compounds from tar and other mineral sources and
had also established rudimentary methods in organic chemical synthesis.[4] The
development of synthetic chemical methods allowed scientists to systematically vary the
structure of chemical substances, and growth in the emerging science
of pharmacology expanded their ability to evaluate the biological effects of these
structural changes.
Epinephrine, norepinephrine, and amphetamineEdit
By the 1890s, the profound effect of adrenal extracts on many different tissue types had
been discovered, setting off a search both for the mechanism of chemical signalling and
efforts to exploit these observations for the development of new drugs. The blood
pressure raising and vasoconstrictive effects of adrenal extracts were of particular
interest to surgeons as hemostatic agents and as treatment for shock, and a number of
companies developed products based on adrenal extracts containing varying purities of
the active substance. In 1897, John Abelof Johns Hopkins University identified the
active principle as epinephrine, which he isolated in an impure state as the sulfate salt.

19
Industrial chemist Jokichi Takamine later developed a method for obtaining epinephrine
in a pure state, and licensed the technology to Parke-Davis. Parke-Davis marketed
epinephrine under the trade name Adrenalin. Injected epinephrine proved to be
especially efficacious for the acute treatment of asthma attacks, and an inhaled version
was sold in the United States until 2011 (Primatene Mist).[5][6] By 1929 epinephrine
had been formulated into an inhaler for use in the treatment of nasal congestion.

20
 CHAPTER 4
-ANALYSIS AND
INTERPRETATION-

21
Q1. Are you satisfied with your job profile at Lark Laboratories?
a) Yes
b) No

No
8%

Yes
92%

92% respondents replied that they are satisfied with their job profile.

22
Q2. From the following, what do you love about your job the most?
a. Job description
b. Company’s vision and motto
c. Work environment at the firm.

(b)
11%

(c) (a)
34% 55%

55% respondents chose their job description as the favourite aspect, 34% love the work
environment at the firm the most, and 11% love the company’s vision.

23
Q3. Are you planning to grow in terms of job responsibility at Lark?

a) Yes b) no

No
0%

Yes
100%

100% respondents replied that they are planning to grow their job responsibilities at the firm.

24
Q4. What motivates you to work in this particular firm and the pharmaceutical field?

a) Your interests, goals and aspirations.

b) economic needs.
c) High job security
d) High job satisfaction
e) Company’s repute.

40%

35%

30%

25%

20%
35%
15%
26%
10%
16%
13%
5% 10%

0%

(a) (b) (c) (d) (e)

35% respondents replied that their high level of job satisfaction motivated them to work at Lark
while 10% give the credit to their economic needs.

25
Q5. Do you plan to leave this job in the future?

a) No
b) Yes

(b)
5%

(a)
95%

95% respondents replied that they do not plan to leave their position at the firm in the future.

26
Q6. What do you feel about the HR policies and benefits at the firm?

a) Perfect
b) Good
c) Not good
d) Room for improvement

50%
45%
40%
35%
30%
25%
45%
20%
15% 30%
10% 20%
5%
5%
0%

(a) (b) (c) (d)

45% respondents feel that the HR policies at the firm are perfect ,20% feel there is room for
improvement while 5% feel that they are not good.

27
Q7. Have you faced any form of bias, harassment or negative treatment during your time
working here?

a) Yes
b) No

(a)
0%

(b)
100%

100% respondents replied that they have never faced bias or negative treatment of any kind at
Lark.

28
Q8. What do you think about the promotion and bonus policies at your firm?

a) Perfect

b) Needs improvement

c) Not good

(a)
22%

(b)
43%

(c)
35%

43% respondents replied that the promotion and bonus policies need improvement.

29
Q9. Do you feel a sense of teamwork in your co-workers?

a) Yes

b) No

No
21%

Yes
79%

79% respondents feel there is a sense of teamwork in employees.

30
Q10. Do you think you participate in the decision making process for your

department/firm?

a) Yes

b) No

No
20%

Yes
80%

80% respondents feel included in the decision making process in the firm.

31
BASES RESULT ANALYSIS
JOB PROFILE 60% AGREE SATISFIED WITH
THEIR NATURE OF
JOB
EMPLOYEER MAJORITYB AGREE EMPLOYEER’S
KINDNESS BEHAVIOUR IS
ACCEPTABLE.
PAID ACC. TO 80% AGREE RENUMERATION
SKILLS SYSTEM IS GOOD.
BREAK TIME 50% DISAGREE BREAK TIME NEEDS
CHANGE.
HOW COLLAGUES 79% TEAMWORK SENSE OF
WORK BELONGINGNESS
AMONG EMPLOYEE
BASIC AMMENITIES 60% AGREE SERVICES ARE
MAINTAINED

32
 MORE FINDINGS FROM PRIMARY RESEARCH

BASES RESULT ANALYSIS

PROMOTIONS AND BONUS LESS THAN 50% AGREE NEEDS IMPROVEMENT

REGULAR SALARY INCREMENT 69% AGREE EMPLOYEES ARE APPROPRIATELY PAID

YOUR PARTICIPATION IN DECISION MAKING 80% AGREE PARTICIPATIVE STYLE OF LEADERSHIP

PAID TRAVELLING EXPENSES 80% AGREE DEARNESS ALLOWANCES ARE WELL PAID

BOSS MOTIVATION AND HELPING 70% AGREE THERE IS TEAMWORK INSTEAD OF

SINGULAR LEADERSHIP

33
 CHAPTER 5
CONCLUSION AND
RECOMMENDATION

34
RECOMMENDATIONS

Following are my recommendations to the firm for increment of employee satisfaction levels :

• Company should follow the modern and latest techniques of employee satisfaction.
• Management needs to hire better HR policy makers.
• Company should understand the value of Human Resource in the success and growth of a
business.
• Bonus and reward schemes should be offered more in order to make employees feel
valued and to increase the level of employee satisfaction.
• Regular and honest feedback from employees is also the key factor which contributes to
the increment of employee satisfaction.
• Communication of needs and requirements(in the job) must be clear from employer as
well as from the employee’s end.
• Employees must be hired only if their goals and needs align with the job position and
description.
• Feedback must be taken from employees at regular intervals to better the work
environment and ascertain smooth working there in.
• Management should get more involved and inclusive with employees
• Regular incentives and rewards must be initiated
• Employees should be motivated and supported in all tasks to establish a safe and secure
work environment. This also helps them feel confident, driven, and explore their full
potential.
• Innovation and risk taking should be appreciated and encouraged among staff by
management.
• Work environment must be made positive, stress-free and fun for employees
• A sense of collectiveness and belonging to the firm must be created and birthed in all
employees.

35
 ANNEXTURE

Questionnaire

Name……………………………….. Gender……..… Time spent working at

LARK (years)………

Age ………………………………… Occupation at LARK LAB INDIA

LTD.………………………

Q1. Are you satisfied with your job profile at Lark Laboratories?
a) Yes
b) No

Q2. From the following, what do you love about your job the most?
a) Job description
b) Company’s vision and motto
c) Work environment at the firm.

Q3. Are you planning to grow in terms of job responsibility at LARK LAB INDIA LTD.?

a) Yes
b) No

Q4. What motivates you to work in this particular firm and the pharmaceutical field?

a) Your interests, goals and aspirations.

b) economic needs.

c) High job security

d) High job satisfaction

e) Company’s repute
36
Q5. Do you plan to leave this job in the future?

a) No
b) Yes

Q6. What do you feel about the HR policies and benefits at the firm?

a) Perfect
b) Good
c) Not good
d) Room for improvement

Q7. Have you faced any form of bias, harassment or negative treatment during your time
working here?

a) Yes
b) No

Q8. What do you think about the promotion and bonus policies at your firm?

d) Perfect

e) Needs improvement

f) Not good

Q9. Do you feel a sense of teamwork in your co-workers?

a) Yes
b) No

Q10. Do you think you participate in the decision making process for your

department/firm?

37
 a) Yes

b) No

Q11. Do employees get paid travelling expenses for work from the firm?

a) Yes
b) No

Q12. Do you receive regular salary increments?

a) Yes
b) No

Q13. Is the status of basic amenities fair in the work environment?

a) Yes
b) No

Q14. Does top management (boss) motivate and help you?

a) Yes
b) No

Q15. Are your managers kind, supportive and do they guide and motivate you when
required?

a) Yes
b) No

38
 CONCLUSION

Drug discovery is the process by which potential drugs are discovered or designed. In
the past most drugs have been discovered either by isolating the active ingredient from
traditional remedies or by serendipitous discovery. Modern biotechnology often
focuses on understanding the metabolic pathways related to a disease state
or pathogen, and manipulating these pathways using molecular
biologyor biochemistry. A great deal of early-stage drug discovery has traditionally
been carried out by universities and research institutions.
Drug development refers to activities undertaken after a compound is identified as a
potential drug in order to establish its suitability as a medication. Objectives of drug
development are to determine appropriate formulation and dosing, as well as to
establish safety. Research in these areas generally includes a combination of in
vitro studies, in vivo studies, and clinical trials. The cost of late stage development
has meant it is usually done by the larger pharmaceutical companies

39
BIBLIOGRAPHY

1) Marketing management Philip kotler.

2) Www.larklaboratories.com
3) www.pharmaceuticalinfo.com
4) www.pharmalabs.com
5) Friends
6) Employees

40